|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc or its employees that the report constitutes an admission that the product, abiomed inc, or its employees, caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
An impella cp device was inserted into the left femoral artery in a 73-year-old female patient with a past medical history of coronary artery disease (cad), presenting in acute myocardial infarction (ami) and cardiogenic shock (cgs), in an out-of-hospital cardiac arrest requiring cardiopulmonary resuscitation (cpr), in scai stage e shock, and on a ventilator for respiratory support, prior to initiation of support.While the patient was in the intensive care unit (icu), there were no pedal pulses.No hematoma to the groin noted; however, there was oozing from the left forward angle suture.The patient had a suspected retroperitoneal bleed from the right femoral sheath site (non-impella site).The physician stated that the right side was a previous sheath site and a femstop was placed there.The left impella groin site was soft, clean, dry, and intact.Three hours after impella support, the family withdrew care, and the patient expired on support.The impella functioned at p-3 at 3.0l/min as intended.Bleeding is a known risk due to the impella's anticoagulation and purge requirements.Limb ischemia can be influenced by patient-specific factors such as peripheral vascular disease, underlying critical illness, hemodynamic instability, anticoagulation status, vasopressor support, and vascular access characteristics.The impella is conservatively being reported for death; however, is unlikely to have contributed to the patient's death, which was most likely due to the clinical condition of a critically ill patient in acute myocardial infarction and cardiogenic shock, complicated by stage e shock.
|
|
D4 serial and primary udi number were revised.H6 component code, type of investigation, investigation findings, and investigation conclusions were updated accordingly based on investigation findings.H11 the impella device was not returned, and the investigation has been completed.Investigation summary - ischemia: the root cause of the injury was unable to be determined due to insufficient clinical details.Major bleed/access site adverse event: the cause of major bleed/access site adverse event was unable to be determined as limited clinical details were provided and no product was returned for review.
|